logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.
  • Medications for Diabetic Peripheral Neuropathic Pain

    FiltersReset Filters
    10 results
    • duloxetine

      (Duloxetine Hydrochloride)
      Rising Pharma Holdings, Inc.
      Usage: Duloxetine delayed-release capsules are indicated for the treatment of major depressive disorder, generalized anxiety disorder (in adults and children 7+), diabetic peripheral neuropathic pain, fibromyalgia (in patients 13+), and chronic musculoskeletal pain in adults.
    • duloxetine

      (Duloxetine)
      Ajanta Pharma USA Inc.
      Usage: Duloxetine delayed-release capsules are indicated for treating major depressive disorder, generalized anxiety disorder (in adults and pediatric patients 7+), diabetic peripheral neuropathic pain, fibromyalgia (in patients 13+), and chronic musculoskeletal pain in adults.
    • lyrica

      (PREGABALIN)
      Parke-Davis Div of Pfizer Inc
      Usage: LYRICA is indicated for managing neuropathic pain related to diabetic peripheral neuropathy and spinal cord injury, postherpetic neuralgia, fibromyalgia, and as adjunctive therapy for partial-onset seizures in patients aged 1 month and older.
    • na

      (Duloxetine delayed-release capsules)
      Qingdao BAHEAL Pharmaceutical Co., Ltd.
      Usage: Duloxetine delayed-release capsules are indicated for treating Major Depressive Disorder, Generalized Anxiety Disorder (in adults and pediatric patients 7+), Diabetic Peripheral Neuropathic Pain, Fibromyalgia, and Chronic Musculoskeletal Pain in adults.
    • nucynta

      (tapentadol hydrochloride)
      Collegium Pharmaceutical, Inc.
      Usage: NUCYNTA ER (tapentadol) is indicated for managing severe, persistent pain in adults requiring long-term opioid treatment when alternatives are inadequate, including neuropathic pain associated with diabetic peripheral neuropathy. It is not suitable for as-needed pain management due to addiction and misuse risks.
    • pregabalin

      (Pregabalin)
      Greenstone LLC
      Usage: Pregabalin is indicated for managing neuropathic pain linked to diabetic peripheral neuropathy, postherpetic neuralgia, spinal cord injury, and fibromyalgia, as well as serving as adjunctive therapy for partial-onset seizures in patients aged 1 month and older.
    • pregabalin

      (PREGABALIN)
      Eskayef Pharmaceuticals Limited
      Usage: Pregabalin Capsules are used for managing neuropathic pain related to diabetic peripheral neuropathy, postherpetic neuralgia, and spinal cord injury. It also serves as adjunctive therapy for partial-onset seizures and for managing fibromyalgia.
    • pregabalin

      (Pregabalin)
      Advagen Pharma Ltd.
      Usage: Pregabalin extended-release tablets are indicated for managing neuropathic pain related to diabetic peripheral neuropathy and postherpetic neuralgia. Their efficacy for fibromyalgia or as adjunctive therapy for partial onset seizures in adults has not been established.
    • pregabalin

      (Pregabalin)
      Ascend Laboratories, LLC
      Usage: Pregabalin is indicated for managing neuropathic pain from diabetic peripheral neuropathy, postherpetic neuralgia, spinal cord injury, and fibromyalgia. It is also used as adjunctive therapy for treating partial-onset seizures in patients aged 1 month and older.
    • pregabalin capsules, cv

      (PREGABALIN capsules, CV)
      Cipla USA Inc.
      Usage: Pregabalin capsules are indicated for managing neuropathic pain related to diabetic peripheral neuropathy and spinal cord injury, postherpetic neuralgia, fibromyalgia, and as adjunctive therapy for partial-onset seizures in patients aged 4 and older.